M&A Deal Summary |
|
|---|---|
| Date | 2019-12-20 |
| Target | Clinical Innovations |
| Sector | Medical Products |
| Buyer(s) | Laborie Medical Technologies |
| Sellers(s) | EQT |
| Deal Type | Add-on Acquisition |
| Deal Value | 525M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1967 |
| Sector | Medical Products |
Laborie Medical Technologies is a manufacturer and supplier of pelvic health and gastrointestinal medical equipment and consumables. Since its founding in 1967, Laborie has been committed to delivering innovative, complete solutions that provide better diagnostics and treatment outcomes to patients worldwide. Laborie Medical Technologies was founded in 1967 and is based in Portsmouth, New Hampshire.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 15 |
| Sector (Medical Products) | 10 of 14 |
| Type (Add-on Acquisition) | 10 of 14 |
| State (Utah) | 1 of 1 |
| Country (United States) | 6 of 10 |
| Year (2019) | 1 of 1 |
| Size (of disclosed) | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-03-12 |
Cogentix Medical
Minnetonka, Minnesota, United States Cogentix Medical is a designer, developer, manufacturer and marketer of products for flexible endoscopy with our unique PrimeSight™ product lines featuring a streamlined visualization system and proprietary sterile disposable microbial barrier providing users with efficient and cost effective endoscope turnover while enhancing patient safety. |
Buy | $214M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-12 |
Pelvalon
Santa Clara, California, United States Pelvalon is a developer of product called the Eclipse™ System, a non-surgical, patient-controlled device for women suffering from fecal incontinence (FI). FI is a pelvic floor disorder that affects one in ten women. Pelvalon was founded in 2010 and is based in Santa Clara, California. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1994 |
| PE ASSETS | 242.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
EQT is a global private equity group that purses a variety of investment strategies around the world. EQT is divided into several investment disciplines, including private capital, real assets, credit, and venture. The Firm's private capital group targets large, market-leading enterprises (investment size of €125 to €1.5 billion) across Europe and the US, as well as mid-market, growth companies (investment size of €40 to €125 million) across the US, Europe, China, and Southeast Asia. The Firm's real assets group seeks to identify control or co-control equity investments (investment size of €500 to €1 billion) in medium-sized infrastructure companies that provide an essential service to society, are recession resilient, and have secure cash flows. EQT's credit group provides flexible, long-term debt capital solutions to medium-sized European businesses, across a wide range of sectors. EQT was established in 1994 and is headquartered in Stockholm, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 126 of 187 |
| Sector (Medical Products) | 9 of 12 |
| Type (Add-on Acquisition) | 52 of 73 |
| State (Utah) | 1 of 1 |
| Country (United States) | 11 of 27 |
| Year (2019) | 14 of 14 |
| Size (of disclosed) | 25 of 42 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-20 |
PSM International
Wales, United Kingdom PSM International is a multinational full-service provider of fastening solutions to a diverse customer base in the automotive, notebook, mobile phone, and general manufacturing industries. PSM International was founded in 1931 and is based in Wales. England. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-01-03 |
SHL Medical
Zug, Switzerland SHL Medical is a developer and manufacturer of advanced drug delivery systems such as autoinjectors and partners to global pharma and biotech firms. SHL Medical was founded in 1989 and is based in Zug, Switzerland. |
Buy | - |
